From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients

M Muscaritoli, J Arends… - Therapeutic advances in …, 2019 - journals.sagepub.com
Tackling malnutrition in cancer patients remains one of the most challenging tasks in clinical
practice. Even though robust evidence exists stressing the role of nutritional status in relation …

The clinical value of nutritional care before and during active cancer treatment

G Aprile, D Basile, R Giaretta, G Schiavo, N La Verde… - Nutrients, 2021 - mdpi.com
Malnutrition and muscle wasting are frequently reported in cancer patients, either linked to
the tumor itself or caused by oncologic therapies. Understanding the value of nutritional care …

Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy

E Cereda, S Cappello, S Colombo, C Klersy… - Radiotherapy and …, 2018 - Elsevier
Background To evaluate the benefit of oral nutritional supplements (ONS) in addition to
nutritional counseling in head and neck cancer (HNC) patients undergoing radiotherapy …

Awareness of cancer-related malnutrition and its management: analysis of the results from a survey conducted among medical oncologists

M Muscaritoli, E Corsaro, A Molfino - Frontiers in oncology, 2021 - frontiersin.org
Cancer is a global major public health problem, particularly in Western countries, where it
represents the second leading cause of death after cardiovascular disease. Malnutrition is …

[HTML][HTML] Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations

R Caccialanza, P Cotogni, E Cereda, P Bossi… - Journal of …, 2022 - ncbi.nlm.nih.gov
Malnutrition is a frequent problem in cancer patients, which leads to prolonged and repeated
hospitalizations, increased treatment-related toxicity, reduced response to cancer treatment …

Pancreatic enzyme replacement therapy in pancreatic cancer

R Pezzilli, R Caccialanza, G Capurso, O Brunetti… - Cancers, 2020 - mdpi.com
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global
cancer deaths in industrialised countries. More than 80% of patients suffer from significant …

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

D Basile, A Parnofiello, MG Vitale… - Journal of cachexia …, 2019 - Wiley Online Library
Background Pancreatic cancer (PC) patients have multiple risk factors for sarcopenia and
loss of skeletal muscle mass (LSMM), which may cause greater treatment toxicities, reduced …

[HTML][HTML] Nutritional therapy in cancer patients receiving chemoradiotherapy: should we need stronger recommendations to act for improving outcomes?

P Cotogni, P Pedrazzoli, E De Waele, G Aprile… - Journal of …, 2019 - ncbi.nlm.nih.gov
One of the challenges during chemotherapy and radiotherapy is to complete the planned
cycles and doses without dose-limiting toxicity. Growing evidence clearly demonstrates the …

The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy

S Uemura, T Iwashita, H Ichikawa, Y Iwasa… - British Journal of …, 2021 - cambridge.org
Sarcopenia, defined as decrease in skeletal muscle mass (SMM) and strength, might be
associated with reduced survival. We investigated the impact of sarcopenia and decrease in …

The impact of nutrition on the lives of patients with digestive cancers: a position paper

M Vitaloni, R Caccialanza, P Ravasco, A Carrato… - Supportive Care in …, 2022 - Springer
Nutritional intervention is an essential part of cancer treatments. Research and clinical
evidence in cancer have shown that nutritional support can reduce length of hospitalisation …